Variant report
Variant | esv18143 |
---|---|
Chromosome Location | chr9:11106326-11109319 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-2 | chr9:11108072-11109984 | XLOC_007644 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CSRNP3 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142305641 | chr9:11106352-11106353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544457785 | chr9:11106402-11106403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs60225237 | chr9:11106419-11106420 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs530248424 | chr9:11106422-11106423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555217435 | chr9:11106442-11106443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554559177 | chr9:11106454-11106455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187407873 | chr9:11106463-11106464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1577125 | chr9:11106487-11106488 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs570228912 | chr9:11106508-11106509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113647358 | chr9:11106516-11106517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191127735 | chr9:11106550-11106551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34778885 | chr9:11106569-11106570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568732674 | chr9:11106596-11106597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs151272354 | chr9:11106622-11106623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4741112 | chr9:11106638-11106639 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs554325414 | chr9:11106644-11106645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72694225 | chr9:11106656-11106657 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs540058839 | chr9:11106657-11106658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536289267 | chr9:11106689-11106690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141594835 | chr9:11106732-11106733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578016568 | chr9:11106741-11106742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537309362 | chr9:11106746-11106747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566476190 | chr9:11106752-11106753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201041033 | chr9:11106763-11106764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183223851 | chr9:11106766-11106767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558158774 | chr9:11106791-11106792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201719856 | chr9:11106812-11106813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575154585 | chr9:11106816-11106817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73397301 | chr9:11106831-11106832 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs113456635 | chr9:11106898-11106899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574931772 | chr9:11106903-11106904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542807541 | chr9:11106910-11106911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540520769 | chr9:11106925-11106926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73399204 | chr9:11106955-11106956 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs532887301 | chr9:11106990-11106991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546194777 | chr9:11107014-11107015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1334034 | chr9:11107045-11107046 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs531622001 | chr9:11107054-11107055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147754432 | chr9:11107076-11107077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372017146 | chr9:11107077-11107078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113432180 | chr9:11107086-11107087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546424784 | chr9:11107108-11107109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566408598 | chr9:11107113-11107114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186828898 | chr9:11107122-11107123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552070195 | chr9:11107136-11107137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376614036 | chr9:11107141-11107142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568797507 | chr9:11107162-11107163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112552023 | chr9:11107219-11107220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541787137 | chr9:11107227-11107228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1577124 | chr9:11107236-11107237 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11104000-11107800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr9:11106400-11106600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr9:11106600-11107200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr9:11106800-11108200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:11107200-11108000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |